Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Exercise of employee share options and restricted stock units in Targovax ASA

Targovax ASA
Posted on: 25 Aug 17

Reference is made to the stock exchange notice of 18 August 2017 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units. As per 25 August 2017,

- 4,502 shares each with a par value of NOK 0.10 were subscribed for by employees holding vested options; and

- 40,984 shares each with a par value of NOK 0.10 were subscribed for by the primary insider and board member, Robert Burns (the "Primary Insider"), holding vested restricted stock units.

The Primary Insider's price per share was NOK 0.10. The Primary Insider has transferred his right to the shares to a third party to sell the corresponding amount of shares in the market in order to cover the Primary Insider's tax cash impact from the RSU settlement. Further information regarding the shares sold by the third party to cover the tax impact of the Primary Insider and the Primary Insiders total holding of shares following the settlement will be published in a separate stock exchange notice as soon as the details are final.  

The new share capital in the Company will accordingly be NOK 5,260,986.70. The share capital increase will be registered in the Register of Business Enterprises (Nw.: Foretaksregisteret) as soon as practically possible.

For further information, please contact:

Erik Digman Wiklund, CFO
Phone: + 47 413 33 536
Email: erik.wiklund@targovax.com

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Targovax ASA via GlobeNewswire
HUG#2129310
GlobeNewswire
globenewswire.com

Last updated on: 26/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.